In this webinar, NCI Program Director Dr. Juli Klemm will give an overview of two trans-NCI programs: Informatics Technology for Cancer Research (ITCR), and the
In this webinar, NCI Program Director Dr. Juli Klemm will give an overview of two trans-NCI programs: Informatics Technology for Cancer Research (ITCR), and the Serological Sciences Network (SeroNet).
The ITCR Program funds investigator-initiated informatics technology development driven by critical needs in cancer research. The presentation will provide an overview of the program’s goals and funding opportunities, as well as highlight some of the supported informatics tools.
SeroNet, established through emergency COVID-19 funding, is leading studies to understand how the immune system responds to SARS-CoV-2 infection and vaccination. The program’s mission, structure, and some key research findings will be discussed.
The Infectious Agents and Cancer Epidemiology Research webinar series is designed to highlight emerging and cutting-edge research related to infection-associated cancers, share scientific knowledge about technologies and methods that may enhance and facilitate infection-associated cancer epidemiology research, and foster cross-disciplinary discussions on infectious agents and cancer epidemiology.
Dr. Juli Klemm is an NCI program director in the Center for Strategic Scientific Initiatives (CSSI) and directs the NCI Informatics Technology for Cancer Research Program supporting open source, investigator-initiated informatics technology development. In addition, Dr. Klemm coordinates the trans-NCI Advisory Committee to CSSI and has been closely involved in organizing SeroNet in support of NCI’s response to the COVID-19 pandemic.
(Tuesday) 2:00 pm - 3:00 pm